Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-03-16 Purchase | 2022-12-15 06:55 am | REPLIGEN CORP | RGEN | EGLINTON MANNER CARRIE Director | 625 | $175.02 | $109,388 | 2,106 (Direct) | View |
| 2022-11-11 Sale | 2022-11-14 5:43 pm | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 25,000 | $200 | $5,000,000 | 212,511 (Direct) | View |
| 2022-09-09 Sale | 2022-09-09 4:14 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 775 | $227.17 | $176,057 | 76,401 (Direct) | View |
| 2022-09-08 Sale | 2022-09-09 4:14 pm | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 26,402 | $224.73 | $5,933,438 | 237,511 (Direct) | View |
| 2022-08-16 Sale | 2022-08-17 4:41 pm | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 6,698 | $252.86 | $1,693,689 | 37,970 (Direct) | View |
| 2022-08-11 Sale | 2022-08-12 4:49 pm | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 4,840 | $254.32 | $1,230,886 | 19,670 (Direct) | View |
| 2022-08-04 Sale | 2022-08-05 4:29 pm | REPLIGEN CORP | RGEN | Gebski Christine See Remarks | 3,357 | $243.01 | $815,785 | 30,735 (Direct) | View |
| 2022-08-03 Sale | 2022-08-04 4:32 pm | REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer | 2,000 | $240.4 | $480,800 | 17,733 (Direct) | View |
| 2022-08-01 Sale | 2022-08-02 5:26 pm | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 2,000 | $220 | $440,000 | 37,187 (Direct) | View |
| 2022-07-21 Sale | 2022-07-22 4:25 pm | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 24,802 | $200 | $4,960,400 | 263,913 (Direct) | View |
| 2022-05-25 Sale | 2022-05-26 5:17 pm | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 14,715 | $150.51 | $2,214,819 | 76,532 (Direct) | View |
| 2022-03-01 Sale | 2022-03-02 9:14 pm | REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director | 2,000 | $198.03 | $396,060 | 1,457 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-11 Exercise | 2022-11-14 5:43 pm | N/A 2028-02-29 | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 25,000 | $0 | 212,511 (Direct) | View |
| 2022-11-11 Exercise | 2022-11-14 5:43 pm | N/A N/A | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 25,000 | $33.87 | 212,511 (Direct) | View |
| 2022-10-07 Exercise | 2022-10-11 5:00 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 466 | $59.52 | 37,080 (Direct) | View |
| 2022-10-07 Exercise | 2022-10-11 5:00 pm | N/A 2029-02-28 | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 466 | $0 | 37,080 (Direct) | View |
| 2022-09-08 Exercise | 2022-09-09 4:14 pm | N/A 2028-02-29 | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 10,000 | $0 | 237,511 (Direct) | View |
| 2022-09-08 Exercise | 2022-09-09 4:14 pm | N/A N/A | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 10,000 | $33.87 | 237,511 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-17 4:41 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 3,047 | $86.1 | 37,970 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-17 4:41 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 970 | $215.58 | 37,970 (Direct) | View |
| 2022-08-16 Exercise | 2022-08-17 4:41 pm | N/A 2030-02-27 | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 4,017 | $0 | 37,970 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 4:49 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 646 | $86.1 | 19,670 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 4:49 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 1,354 | $59.52 | 19,670 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 4:49 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 2,000 | $33.05 | 19,670 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-12 4:49 pm | N/A 2026-12-14 | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 4,000 | $0 | 19,670 (Direct) | View |
| 2022-08-03 Exercise | 2022-08-04 4:32 pm | N/A 2030-04-01 | REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer | 2,000 | $0 | 17,733 (Direct) | View |
| 2022-08-03 Exercise | 2022-08-04 4:32 pm | N/A N/A | REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer | 2,000 | $94.33 | 17,733 (Direct) | View |
| 2022-07-21 Exercise | 2022-07-22 4:25 pm | N/A N/A | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 15,154 | $32.4 | 263,913 (Direct) | View |
| 2022-07-21 Exercise | 2022-07-22 4:25 pm | N/A 2028-02-29 | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 20,154 | $0 | 263,913 (Direct) | View |
| 2022-07-21 Exercise | 2022-07-22 4:25 pm | N/A N/A | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 5,000 | $33.87 | 263,913 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 8:25 pm | 2023-05-26 2032-05-26 | REPLIGEN CORP | RGEN | Mhatre Rohin Director | 4,122 | $0 | 4,579 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 8:23 pm | 2023-05-26 2032-05-26 | REPLIGEN CORP | RGEN | Konstantinov Konstantin Director | 4,330 | $0 | 4,330 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 8:21 pm | 2023-05-26 2032-05-26 | REPLIGEN CORP | RGEN | DAWES KAREN A Director | 2,209 | $0 | 78,741 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 8:20 pm | 2023-05-26 2032-05-26 | REPLIGEN CORP | RGEN | BARTHELEMY NICOLAS Director | 1,832 | $0 | 3,379 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 8:17 pm | 2023-05-26 2032-05-26 | REPLIGEN CORP | RGEN | MUIR GLENN P Director | 1,832 | $0 | 8,194 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-31 8:15 pm | 2023-05-26 2032-05-26 | REPLIGEN CORP | RGEN | EGLINTON MANNER CARRIE Director | 3,512 | $0 | 3,969 (Direct) | View |
| 2022-05-13 Tax Withholding | 2022-05-17 5:00 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 712 | $150.4 | 20,110 (Direct) | View |
| 2022-05-13 Tax Withholding | 2022-05-17 4:59 pm | N/A N/A | REPLIGEN CORP | RGEN | Gebski Christine See Remarks | 335 | $150.4 | 34,092 (Direct) | View |
| 2022-05-13 Tax Withholding | 2022-05-17 4:59 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 712 | $150.4 | 39,187 (Direct) | View |
| 2022-04-01 Tax Withholding | 2022-04-04 5:57 pm | N/A N/A | REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer | 335 | $188.02 | 9,733 (Direct) | View |
| 2022-03-08 Exercise | 2022-03-09 8:02 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 1,214 | $59.52 | 56,180 (Direct) | View |
| 2022-03-08 Exercise | 2022-03-09 8:02 pm | N/A 2028-03-01 | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 4,166 | $0 | 56,180 (Direct) | View |
| 2022-03-08 Exercise | 2022-03-09 8:02 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 2,952 | $33.87 | 56,180 (Direct) | View |
| 2022-03-01 Tax Withholding | 2022-03-03 3:52 pm | N/A N/A | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 7,292 | $194.06 | 199,315 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-02 9:14 pm | N/A N/A | REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director | 1,000 | $38.76 | 1,457 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-02 9:14 pm | N/A 2030-11-11 | REPLIGEN CORP | RGEN | RYAN THOMAS F JR Director | 1,000 | $0 | 1,457 (Direct) | View |
| 2022-02-27 Tax Withholding | 2022-03-02 8:19 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 2,534 | $196.7 | 20,822 (Direct) | View |
| 2022-02-27 Option Award | 2022-03-02 8:19 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 4,234 | $0 | 20,822 (Direct) | View |
| 2022-02-27 Tax Withholding | 2022-03-02 7:52 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 3,824 | $196.7 | 35,733 (Direct) | View |
| 2022-02-27 Option Award | 2022-03-02 7:52 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 5,922 | $0 | 35,733 (Direct) | View |
| 2022-02-27 Tax Withholding | 2022-03-02 7:49 pm | N/A N/A | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 19,292 | $196.7 | 206,607 (Direct) | View |
| 2022-02-27 Option Award | 2022-03-02 7:49 pm | N/A N/A | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 30,074 | $0 | 206,607 (Direct) | View |
| 2022-02-27 Tax Withholding | 2022-03-02 7:47 pm | N/A N/A | REPLIGEN CORP | RGEN | Gebski Christine See Remarks | 1,060 | $196.7 | 34,427 (Direct) | View |
| 2022-02-24 Tax Withholding | 2022-02-28 8:04 pm | N/A N/A | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 1,170 | $189.21 | 216,132 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 8:04 pm | N/A 2032-02-24 | REPLIGEN CORP | RGEN | Hunt Anthony Chief Executive Officer | 36,162 | $0 | 216,132 (Direct) | View |
| 2022-02-24 Tax Withholding | 2022-02-28 7:10 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 269 | $189.21 | 38,045 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 7:10 pm | N/A 2032-02-24 | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 7,853 | $0 | 38,045 (Direct) | View |
| 2022-02-24 Tax Withholding | 2022-02-28 7:10 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 188 | $189.21 | 21,845 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 7:10 pm | N/A 2032-02-24 | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 4,849 | $0 | 21,845 (Direct) | View |
| 2022-02-24 Tax Withholding | 2022-02-28 7:09 pm | N/A N/A | REPLIGEN CORP | RGEN | Gebski Christine See Remarks | 181 | $189.21 | 38,208 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 7:09 pm | N/A 2032-02-24 | REPLIGEN CORP | RGEN | Gebski Christine See Remarks | 4,845 | $0 | 38,208 (Direct) | View |
| 2022-02-24 Tax Withholding | 2022-02-28 7:07 pm | N/A N/A | REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer | 188 | $189.21 | 14,380 (Direct) | View |
| 2022-02-24 Option Award | 2022-02-28 7:07 pm | N/A 2032-02-24 | REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer | 7,678 | $0 | 14,380 (Direct) | View |
| 2022-02-17 Tax Withholding | 2022-02-22 7:37 pm | N/A N/A | REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer | 334 | $182.42 | 6,890 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 7:37 pm | N/A N/A | REPLIGEN CORP | RGEN | Bylund James Chief Operating Officer | 900 | $0 | 6,890 (Direct) | View |
| 2022-02-17 Tax Withholding | 2022-02-22 7:34 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 175 | $182.42 | 17,184 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 7:34 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 450 | $0 | 17,184 (Direct) | View |
| 2022-02-17 Tax Withholding | 2022-02-22 7:31 pm | N/A N/A | REPLIGEN CORP | RGEN | Gebski Christine See Remarks | 224 | $182.42 | 33,544 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 7:31 pm | N/A N/A | REPLIGEN CORP | RGEN | Gebski Christine See Remarks | 450 | $0 | 33,544 (Direct) | View |
| 2022-02-17 Tax Withholding | 2022-02-22 7:30 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 332 | $182.42 | 30,461 (Direct) | View |
| 2022-02-17 Option Award | 2022-02-22 7:30 pm | N/A N/A | REPLIGEN CORP | RGEN | Snodgres Jon Chief Financial Officer | 900 | $0 | 30,461 (Direct) | View |
| 2021-12-14 Tax Withholding | 2021-12-15 9:30 pm | N/A N/A | REPLIGEN CORP | RGEN | KURIYEL RALF Senior VP R & D | 445 | $252.53 | 16,909 (Direct) | View |